论文部分内容阅读
目的探讨核受体辅阻遏子(nuclear receptor corepressor,NCoR)在雄激素非依赖性前列腺癌(androgen independent prostate cancer,AIPC)的表达和临床意义。方法采用免疫组化两步法检测15例AIPC、20例雄激素依赖性前列腺癌(androgen dependent prostate cancer,ADPC)、20例前列腺增生(benign prostatic hyperplasia,BPH)标本雄激素受体(androgen receptor,A